Page last updated: 2024-11-07

androsterone and Diabetic Retinopathy

androsterone has been researched along with Diabetic Retinopathy in 5 studies

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, LJ1
Cullen, JF3
Ireland, JT2
Nolan, J1
Clarke, BF1
Oliver, MF2
Fitzgerald, JD1
Vannas, S1
Esilä, R1
Tuovinen, E1

Trials

2 trials available for androsterone and Diabetic Retinopathy

ArticleYear
A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Diabetes, 1968, Volume: 17, Issue:7

    Topics: Adult; Aged; Androsterone; Anticholesteremic Agents; Butyrates; Cholesterol; Clinical Trials as Topi

1968
A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Transactions of the ophthalmological societies of the United Kingdom, 1964, Volume: 84

    Topics: Adult; Aged; Androsterone; Anticholesteremic Agents; Butyrates; Chlorpropamide; Cholesterol; Diabeti

1964

Other Studies

3 other studies available for androsterone and Diabetic Retinopathy

ArticleYear
[Action mechanism and clinical success of Regelan (Clofibrate)].
    Wiener klinische Wochenschrift, 1967, Sep-29, Volume: 79, Issue:39

    Topics: Androsterone; Anticholesteremic Agents; Butyrates; Cholesterol; Diabetic Retinopathy; Fibrinogen; Hu

1967
The treatment of diabetic retinopathy.
    Geriatrics, 1968, Volume: 23, Issue:7

    Topics: Adult; Androsterone; Anticholesteremic Agents; Blindness; Butyrates; Diabetic Retinopathy; Female; H

1968
Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Acta ophthalmologica, 1968, Volume: 46, Issue:2

    Topics: Adult; Aged; Androsterone; Anticholesteremic Agents; Arteriosclerosis; Butyrates; Cholesterol; Diabe

1968